Syngene International, an unit of Biocon, has tied up with HiMedia Laboratories to manufacture and distribute its Elisa COVID-19 testing kits. HiMedia will manufacture the kits at its facility in Mumbai and distribute it across the country. Syngene has developed this kit and will do a tech-transfer for developing the prototypes for submission to Central Drugs Standard Control Organisation for approval.
Syngene COO Mahesh Bhalgat said, “At a time when the number of Covid-19 cases is increasing at an alarming rate across the country, there is an urgent need to make available reliable testing kits using advanced technology to test patients and identify positive cases.”
The company said that the test kit identifies the presence of COVID-19 antibodies in blood samples and confirms if a patient has been exposed to the virus. It has a capacity to test samples together in a single run and generates results within 3 hours.
Vishal Warke, director of R&D, cell culture and immunology at HiMedia Laboratories said, ” We are happy to partner with Syngene in manufacturing and distributing their Elisa kits. This partnership brings together our mutual expertise in research and manufacturing and will further strengthen our fight against the Covid-19 pandemic.”
